Medically reviewed by Dr. Muralidhar Muddusetty, Surgical Oncologist (Head & Neck Lead) · Last reviewed June 2026
Oral cancer treatment is unique among cancers in how directly it affects daily function — speech, swallowing, chewing, and appearance all depend on whether the surgical team can not only remove the tumour but also rebuild the area with high-quality reconstruction. CION runs Hyderabad's dedicated oral cancer network: NCCN-protocol care, IMRT chemoradiation, and NABH-accredited partners for head and neck surgery with free flap reconstruction.
Most patients begin by searching for an oral cancer hospital in Hyderabad. The doctor matters — but oral cancer is the cancer where the team and the institutional capability matter most. India carries roughly one-third of the global oral cancer burden, driven primarily by tobacco chewing (gutka, khaini), betel quid (paan), smoking, and alcohol.
For those already diagnosed, the central decisions are whether the surgery is performed by a trained head and neck surgical oncologist, whether free flap microvascular reconstruction is available to rebuild the area where the tumour is removed (critical for preserving speech and swallowing), and whether the hospital offers a complete functional rehabilitation team including speech therapy, swallowing therapy, dental and prosthodontic specialists, and nutritional support.
This page gives you an honest framework — eight institutional signals that separate hospitals that can manage oral cancer well from hospitals that simply offer the service — and explains how CION is built around them. Use the framework on every hospital you shortlist. If a hospital can't answer in writing, it should fall off your list.
India accounts for nearly one-third of global oral cancer cases — driven primarily by tobacco chewing, betel quid (paan), smoking, and alcohol. The good news: most oral cancers are visible to the eye or felt as palpable lumps inside the mouth, and most are preceded by visible precancerous changes (such as white patches called leukoplakia, red patches called erythroplakia, or stiffening of the mouth lining called oral submucous fibrosis, which is closely linked to betel quid use). Regular dental checkups, self-examination, and prompt biopsy of suspicious patches are among the most powerful early-detection strategies available — and significantly improve survival when cancer is caught at the earliest stage. Source: NCCN / WHO Global Cancer Observatory.
These are the eight institutional signals that matter most for oral cancer. Each is verifiable. Each is non-negotiable. Ask the question, get it in writing, and walk away if you can't.
Oral cancer surgery should be performed by a head and neck surgical oncologist — a surgeon specifically trained in head and neck cancers, distinct from a general ENT surgeon or general surgeon. Around this lead surgeon, the team needs a microvascular reconstructive surgeon who can perform free flap reconstruction (transplanting tissue from another part of the body to rebuild the affected area), a medical oncologist experienced with concurrent cisplatin chemoradiation and modern immunotherapy, a radiation oncologist trained in IMRT, a maxillofacial surgeon and prosthodontist for jaw reconstruction and prosthetic rehabilitation, a speech and swallowing therapist, a dental oncologist, a nutritionist, and a pathologist with head and neck experience. Ask for named team credentials in writing.
An oral cancer tumour board reviews biopsy results, scans, and physical examination findings together. The board assigns a TNM stage, debates the surgical approach (the extent of removal, the type of neck dissection needed for lymph nodes), plans the reconstruction (which free flap will be used to rebuild speech and swallowing function), and decides whether radiation or chemoradiation will follow surgery. For locally advanced or unresectable cases, the board may recommend definitive chemoradiation as the primary treatment.
Oral cancer surgery has a strong volume-outcome relationship. The most important institutional capability is free flap microvascular reconstruction — where tissue is taken from the forearm, leg, or thigh along with its blood supply and transplanted to rebuild the area where the tumour was removed, with the blood vessels reconnected to vessels in the neck under a microscope. Without this capability, large tumour removals leave defects that severely compromise speech, swallowing, and appearance. Ask: "How many oral cancer surgeries did your team perform last year? How many included free flap reconstruction? What is the flap success rate?" Specific numbers indicate transparency.
Oral cancer diagnosis is straightforward — a tissue biopsy of any suspicious lesion. Staging requires contrast CT and MRI of the head and neck to measure tumour depth and assess lymph node involvement; PET-CT is useful for advanced cases to rule out distant spread. Ultrasound of the neck helps assess lymph nodes. Panendoscopy — a comprehensive examination of the mouth, throat, voice box, and upper oesophagus under anaesthesia — is important for tobacco users because second primary cancers can occur elsewhere in the upper aerodigestive tract.
Oral cancer treatment often involves a 6–7 week course of daily radiation, typically given as intensity-modulated radiation (IMRT) that precisely targets the tumour while sparing the salivary glands and other healthy tissues. Concurrent cisplatin chemotherapy — given alongside radiation — is the standard for locally advanced cases or as definitive treatment when surgery isn't chosen. For unfit patients, cetuximab is an alternative to cisplatin. For recurrent or metastatic disease, immunotherapy drugs (pembrolizumab, nivolumab) are part of the standard pathway. Daily radiation visits over six to seven weeks add up — proximity matters.
Oral cancer care occasionally calls on specialised procedures — transoral robotic surgery for selected oropharyngeal cases, brachytherapy (a form of internal radiation) for tongue and lip cancers, and extensive composite resections requiring multiple flap reconstructions. Beyond surgery itself, comprehensive functional rehabilitation — speech therapy, swallowing therapy, dental rehabilitation with implants and obturators for jaw defects, prosthodontic rehabilitation, and management of trismus (limited mouth opening after treatment) — is what separates good surgical outcomes from good functional outcomes. NABH-accredited partners signal audited surgical and procedural safety.
Oral cancer treatment is a substantial financial commitment — major surgery with reconstruction, six to seven weeks of chemoradiation, and ongoing dental and prosthodontic rehabilitation that can extend over many months. A hospital that isn't empanelled for your insurance or ArogyaSri at the specific centre where your procedure happens can derail planning at the worst moment. Confirm empanelment status by centre and by procedure — especially for free flap reconstruction and immunotherapy, which have specific scheme rules.
Oral cancer survivors face a unique long-term set of issues — chronic dry mouth from radiation damage to salivary glands, difficulty swallowing and chewing requiring ongoing speech and swallowing therapy, dental decay accelerated by radiation, ill-fitting dentures after jaw reconstruction needing prosthodontic adjustment, weight loss from nutritional difficulties, and the high risk of second primary cancers in tobacco users. Tobacco and betel quid cessation support is a critical part of survivorship. A hospital an hour away makes every visit a half-day; a network of centres close to home — same panel, same protocols, shared records — makes continuity sustainable.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Bring your biopsy and scans. Get a written second opinion with tumour-board review and reconstruction planning — free, and yours to keep. Decisions for healing, not billing.
Hyderabad has all three models. They are not interchangeable. The right one depends on whether you have access to a high-volume head and neck surgical oncologist with microvascular reconstruction support and the full functional rehabilitation team. Here's an honest comparison.
| Hospital archetype | Strengths for oral cancer | Trade-offs | Best fit for |
|---|---|---|---|
| Dedicated cancer-specialty hospital or network | Tumour-board review with reconstruction planning. IMRT chemoradiation infrastructure. Tight oncology coordination. Established functional rehabilitation pathway with speech, swallowing, and dental services. Partner pathway for head and neck surgery with free flap reconstruction. | Major surgery with reconstruction itself coordinated through partners. Strong networks solve this with NABH-accredited tie-ups to high-volume head and neck centres. | Most oral cancer patients — across all stages where multidisciplinary surgical, radiation, and rehabilitation care matters. |
| Multi-specialty general hospital with in-house head and neck surgery | In-house head and neck surgery team if comprehensive. Single-campus coordination across surgery, reconstruction, ICU, and ENT. | Oncology depth and IMRT chemoradiation delivery varies. Microvascular reconstruction availability must be verified. Functional rehabilitation pathway varies. | Patients prioritising single-campus care if and only if a dedicated head and neck surgical oncologist and microvascular reconstructive surgeon are both on staff. |
| Ayurveda hospital | Symptom palliation and post-treatment recovery support. Some patients value the holistic framing. | Not evidence-based as primary curative treatment. Should never delay surgery or chemoradiation in oral cancer — where time-to-treatment matters and disease progression is rapid. | Strictly as an add-on to allopathic oncology care. Discuss any Ayurveda use openly with your medical oncologist. |
CION is not a single hospital. It is a dedicated cancer-specialty network — 35+ centres across Telangana and Andhra Pradesh — with the same panel of oncologists, the same NCCN protocols, and the same tumour-board governance at every site. The network is architected specifically around the eight signals above.
Hospital infrastructure for oral cancer is tiered at CION. Surveillance examinations, biopsy follow-up, day-care chemotherapy and immunotherapy, speech and swallowing therapy sessions, nutritional counselling, and dental reviews happen at the centre nearest your home. Major surgery with free flap reconstruction, transoral robotic surgery, IMRT chemoradiation, and brachytherapy run through NABH-accredited partner hospitals with verified head and neck surgical expertise. The same oncology team that consults at one centre stays with you across the network.
Contrast CT, MRI, and PET-CT imaging — with the head and neck protocols needed to measure tumour depth and assess lymph node involvement — are available across CION's Hyderabad centres. Imaging is reviewed by treating oncologists alongside the CION pathology team. For tobacco users, panendoscopy to rule out second primary cancers elsewhere in the upper aerodigestive tract is coordinated through partner gastroenterology and ENT services.
Many oral cancers are preceded by visible precancerous changes — leukoplakia (white patches), erythroplakia (red patches), and oral submucous fibrosis (a stiffening of the mouth lining closely linked to betel quid use). CION evaluates and manages these precancerous lesions with biopsy when needed and structured surveillance, integrating tobacco and betel quid cessation support. Early intervention at the precancerous stage prevents many oral cancers.
CION's centres have day-care infusion bays. Concurrent cisplatin chemoradiation, induction chemotherapy with TPF (three-drug combination), cetuximab as an alternative to cisplatin in unfit patients, and pembrolizumab or nivolumab immunotherapy for recurrent or metastatic disease are all administered close to home. Oncology-trained nursing, infusion-reaction protocols for platinum-based chemotherapy, and on-site oncologist supervision are standard at every centre.
Where an oral cancer case requires wide local excision of the tumour, selective or modified radical neck dissection, segmental or marginal mandibulectomy, maxillectomy, free flap microvascular reconstruction with tissue from the forearm, leg, or thigh, transoral robotic surgery for selected cases, or brachytherapy, CION coordinates the procedure through NABH-accredited partner hospitals with established head and neck cancer programs and microvascular reconstruction expertise.
Oral cancer survivors face permanent changes to speech, swallowing, chewing, and appearance — and the quality of functional rehabilitation directly determines quality of life. Speech therapy, swallowing therapy, dental rehabilitation with extractions before radiation and implants afterwards, prosthodontic rehabilitation including obturators for palate defects, nutritional support (often including a feeding tube during the most intense weeks of chemoradiation), jaw exercises for trismus, lymphoedema management for the neck after dissection, and psychological support are all coordinated within the CION network. Tobacco and betel quid cessation counselling is integrated throughout.
Every oral cancer case at CION is reviewed by the multidisciplinary tumour board before the treatment plan is finalised. The board debates the TNM stage, surgical approach including the extent of resection and the type of neck dissection, reconstruction planning including which flap is best suited, adjuvant radiation or chemoradiation decisions, biomarker-driven options where relevant, and functional rehabilitation planning. The board produces a written summary that becomes part of your records — and yours to keep. You can take it to any second opinion, anywhere.
Specifics beat vague claims. Here is the verifiable network footprint behind CION's oral cancer pathway.
| Network metric | CION figure |
|---|---|
| Centres across Telangana & Andhra Pradesh | 35+ |
| Day-care chemotherapy infusion bays | At every city centre |
| Super-specialist oncologists on panel | 17 |
| Combined oncology experience | 150+ years |
| Patients treated network-wide | 15,000+ |
| Oral cancer 1-year survival (CION vs national) | 80.0% vs 71.6%* |
| Google review rating | 4.8★ |
| Head & neck surgery & free flap reconstruction partner accreditation | NABH-accredited |
| Tumour-board review on every case (with reconstruction planning) | Yes — written summary |
| Comprehensive functional rehabilitation (speech, swallowing, dental, prosthodontics) | Integrated pathway |
| Written second opinion | Free (worth ₹950) |
| Insurance and ArogyaSri accepted | Yes — empanelled |
| EMI facility for self-paying patients | Available on selected packages |
*1-year survival. Source: ICMR / NCRP. Survival statistics are population-level estimates and do not predict outcomes for an individual case.
Oral cancer treatment is a substantial commitment — major surgery with reconstruction, six to seven weeks of chemoradiation, and ongoing dental and prosthodontic rehabilitation. Financial clarity at the start is part of clinical care, not separate from it. CION provides a written, itemised treatment plan and cost estimate before any decision is finalised.
Eligible patients can access state-scheme coverage at empanelled CION centres.
Most major insurers and TPAs accepted — pre-authorisation handled by the CION insurance desk.
Available for self-paying patients on selected treatment packages.
Surgery, free flap reconstruction, IMRT chemoradiation, immunotherapy if needed, dental and prosthodontic rehabilitation, and supportive care — itemised before treatment begins.
Free flap reconstruction and immunotherapy in particular have specific scheme rules. The CION insurance desk will confirm coverage and pre-authorisation requirements before your treatment begins. Ask for written confirmation.
Medical Disclaimer: The information on this page is provided for general educational purposes and reflects current clinical practice in oral cancer oncology at the time of last medical review. It is not a substitute for individual medical advice, diagnosis, or treatment. Treatment decisions, drug choices, dosing, surgical approach, and follow-up schedules must be made by a qualified physician evaluating the specific patient. Survival statistics cited are population-level estimates drawn from public registries and do not predict outcomes for an individual case. Always discuss your specific situation with a qualified medical or surgical oncologist before acting on any information presented here.
Last Medically Reviewed: June 2026 by Dr. Muralidhar Muddusetty — Surgical Oncologist, MBBS (AIIMS), MS Surgery (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh).
Real patients, real recoveries. See how a tumour-board-led pathway with reconstruction planning changed what came next for them.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.No single hospital is automatically the right one — and for oral cancer, the most important factors are whether the surgery is performed by a trained head and neck surgical oncologist (a surgeon specifically trained in head and neck cancers), whether free flap microvascular reconstruction is available in-house or via a verified partner pathway, and whether the hospital provides comprehensive functional rehabilitation including speech, swallowing, dental, and prosthodontic care. CION Cancer Clinics meets these criteria across its centres in Hyderabad and a network spanning 35+ centres across Telangana & AP.
Verify eight signals in writing: head and neck surgical oncology-led multidisciplinary team, tumour-board review with TNM staging and reconstruction planning, annual head and neck surgery volume with free flap reconstruction capability, biopsy and detailed imaging infrastructure, day-care cisplatin chemoradiation and immunotherapy capacity near home, NABH-accredited partners for advanced surgery and comprehensive functional rehabilitation (speech, swallowing, dental, prosthodontics), insurance and ArogyaSri empanelment, and continuity of care including tobacco cessation support.
Outcomes depend strongly on stage at diagnosis. At CION, the 1-year survival for oral cancer is 80.0% versus a national average of 71.6% (a difference of +8.4 percentage points).* Survival is highest when the cancer is caught early and treated with high-quality surgery and reconstruction, and the hospital you choose directly affects whether you receive comprehensive surgical, reconstructive, and rehabilitative care. *1-year survival. Source: ICMR / NCRP.
Costs vary by stage and pathway. Indicative ranges: wide local excision with neck dissection ₹1.5-3 lakh; composite resection with free flap microvascular reconstruction ₹3-6 lakh; mandibulectomy with reconstruction ₹3-7 lakh; transoral robotic surgery ₹3-5 lakh (via NABH-accredited partner); a full course of IMRT chemoradiation ₹3-5 lakh; brachytherapy ₹1-2 lakh; each cisplatin chemoradiation cycle ₹15,000-30,000; pembrolizumab immunotherapy ₹1.5-2 lakh per cycle; prosthodontic rehabilitation ₹50,000-2 lakh depending on complexity. CION provides a written treatment plan and itemised cost estimate before treatment begins, with an EMI facility available on selected packages.
For oral cancer, the deciding factor is whether the hospital provides comprehensive head and neck cancer care — high-volume surgery, free flap microvascular reconstruction, IMRT, and the full functional rehabilitation team (speech, swallowing, dental, prosthodontics, nutrition). A cancer-specialty hospital or network usually offers tighter oncology workflows including tumour-board review, dedicated chemoradiation infrastructure, oncology-trained nursing, and integrated rehabilitation. A multi-specialty general hospital with an in-house high-volume head and neck cancer program and reconstruction expertise can also be an excellent fit. The structural fit for most patients is the cancer-specialty pathway with NABH-accredited surgical partners.
Yes. Free flap microvascular reconstruction — where tissue is taken from the forearm, leg, or thigh along with its blood supply and transplanted to rebuild the area where the tumour was removed, with the blood vessels reconnected to vessels in the neck under a microscope — is available in Hyderabad at select centres with trained microvascular reconstructive surgeons. CION coordinates free flap reconstruction through NABH-accredited partner hospitals. This is the most important functional capability for oral cancer — without high-quality reconstruction, swallowing, speech, and chewing are significantly compromised after major tumour removal.
Yes. Intensity-modulated radiotherapy (IMRT) — a precise radiation technique that targets the tumour while sparing surrounding healthy tissues including the salivary glands — is the modern standard for oral cancer radiation and is widely available in Hyderabad. Concurrent cisplatin chemoradiation (chemotherapy given alongside radiation) is the standard for locally advanced cases or as definitive treatment when surgery is not chosen. For recurrent or metastatic oral cancer, immunotherapy drugs called pembrolizumab and nivolumab are available, particularly for PD-L1-positive tumours. CION administers all of these regimens with on-site oncologist supervision.
Many qualified hospitals are empanelled for ArogyaSri and most major cashless insurers — but empanelment varies by centre and by procedure. Free flap reconstruction and immunotherapy in particular have specific scheme rules. CION Cancer Clinics is empanelled for ArogyaSri and accepts most major cashless insurance providers and TPAs. Request a written cost estimate and confirm pre-authorisation before treatment begins, especially for composite resection with reconstruction.
Several Hyderabad hospitals hold NABH accreditation — the Indian healthcare quality standard covering patient safety, infection control, and clinical governance. CION's partner hospitals for head and neck surgery, free flap microvascular reconstruction, transoral robotic surgery, and IMRT radiotherapy are NABH-accredited, giving patients audited assurance on infection control and surgical safety for these complex procedures.
Confirm in writing: head and neck surgical oncologist (not a general ENT or general surgeon), microvascular reconstructive surgeon for free flap reconstruction, dedicated head and neck operating theatre with operating microscope for microvascular work, contrast CT and MRI capability, on-site frozen-section pathology for margin assessment during surgery, ICU with experience in managing tracheostomy and airway after head and neck surgery, blood-bank access, in-house or networked IMRT chemoradiation, speech and swallowing therapy team, prosthodontic and dental rehabilitation service, nutritional support and feeding tube management, NABH accreditation, room categories, and your surgeon's annual oral cancer case volume and reconstruction outcomes.